Morphine-pathway block in top1 poppies
Authors:
- Barry J. PogsonBPBarry J. Pogson
- Iain W. WilsonIain W. Wilson
- Toni M. KutchanTKToni M. Kutchan
- Meinhart H. ZenkMZMeinhart H. Zenk
- Wayne L. GerlachWGWayne L. Gerlach
- Anthony J. FistAFAnthony J. Fist
- Philip J. LarkinPLPhilip J. Larkin
- 22 September 2004
- journal article
- Published by Springer Nature in Nature
- Vol. 431 (7007) , 413-414
Abstract
The opium poppy is a source of the pharmaceuticals codeine, morphine and their derived analgesics. Here we describe the initial characterization of the poppy mutant known as top1 (for 'thebaine oripavine poppy 1'), which accumulates the morphine and codeine precursors thebaine and oripavine and does not complete their biosynthesis into morphine and codeine. The original discovery of top1 stimulated a re-engineering of the opioid industry in the island state of Tasmania, which grows over 40% of the world's licit opiates, in order to produce thebaine and oripavine efficiently from morphine-free poppy crops to provide precursors for highly effective analgesics and for treatment of opioid addiction.Keywords
This publication has 6 references indexed in Scilit:
- A Tale of Three Cell Types: Alkaloid Biosynthesis Is Localized to Sieve Elements in Opium PoppyThe Plant Cell, 2003
- Immunocytological localization of two enzymes involved in berberine biosynthesisPlanta, 2002
- The cell and developmental biology of alkaloid biosynthesisTrends in Plant Science, 2000
- Heterologous expression of alkaloid biosynthetic genes — a reviewGene, 1996
- A Second Pathway for the Terminal Steps in the Biosynthesis of MorphinePlanta Medica, 1984
- Biosynthetic conversion of thebaine to codeineJournal of the American Chemical Society, 1972